Search - tctmd.com

Displaying 281 - 300 of 455

Sort: Relevancy | Date

News Daily News

Subestudio del STREAM: Los STEMI Abortados son Más Frecuentes con una Estrategia Precoz de Fibrinolisis

June 27, 2014

News Daily News

Study of STEMI Care in China Exposes Crucial Treatment Gaps

L.A. McKeown

June 27, 2014

News Daily News

STREAM Substudy: Aborted STEMI More Common with Strategy of Early Fibrinolysis

June 27, 2014

Presentation

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Presenter: J.A. Udell

June 17, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Daily News

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

Jason Kahn

May 15, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

Presentation

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Presenter: D. Lindholm

April 25, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Caitlin E. Cox

April 09, 2014

News Daily News

Registro FAST-MI: La Fibrinolisis y la PCI, Primaria arrojan una Supervivencia Similar a los 5 Años en Pacientes STEMI

L.A. McKeown

April 03, 2014

News Daily News

FAST-MI Registry: Fibrinolysis, Primary PCI Yield Similar 5-Year Survival in STEMI Patients

L.A. McKeown

April 03, 2014

News Conference News ACC 2014

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Jason Kahn

March 31, 2014

News Conference News ACC 2014

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Jason Kahn

March 31, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

Advertisement

Subestudio del STREAM: Los STEMI Abortados son Más Frecuentes con una Estrategia Precoz de Fibrinolisis

Study of STEMI Care in China Exposes Crucial Treatment Gaps

STREAM Substudy: Aborted STEMI More Common with Strategy of Early Fibrinolysis

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Registro FAST-MI: La Fibrinolisis y la PCI, Primaria arrojan una Supervivencia Similar a los 5 Años en Pacientes STEMI

FAST-MI Registry: Fibrinolysis, Primary PCI Yield Similar 5-Year Survival in STEMI Patients

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content